1229588

GlaxoSmithKline LLC — FEI 1033964

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
April 19, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Zebulon, NC (United States)

Citations

IDCFRDescription
241921 CFR 211.198(a)Complaint Handling Procedure